GCIA
GCVRZ

Gabelli & Co Investment Advisers’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,100
Closed -$7K – 220
2015
Q2 		$7K Sell
10,100
-43,671
-81% -$30.2K ﹤0.01% 175
2015
Q1 		$36K Hold
53,771
– – 0.01% 155
2014
Q4 		$42K Sell
53,771
-264,470
-83% -$181K 0.01% 146
2014
Q3 		$148K Buy
318,241
+4,200
+1% +$2.04K 0.02% 160
2014
Q2 		$157K Buy
314,041
+30,000
+11% +$14.5K 0.03% 123
2014
Q1 		$88K Buy
284,041
+213,871
+305% +$79.5K 0.02% 117
2013
Q4 		$24K Sell
70,170
-820,288
-92% -$991K 0.01% 120
2013
Q3 		$1.8M Buy
890,458
+27,882
+3% +$53.1K 0.39% 52
2013
Q2 		$1.64M Buy
+862,576
New +$1.52M 0.43% 41

Other funds holding GCVRZ

WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Gabelli & Co Investment Advisers's GCVRZ Position: Q3 2015 in Review

Gabelli & Co Investment Advisers sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2015, closing a stake of 10,100 shares — an estimated $7K sold.

Gabelli & Co Investment Advisers first reported a position in GCVRZ in Q2 2013 and held it in 9 quarters. The position peaked at $1.8M in Q3 2013. 117 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2015.

  • Gabelli & Co Investment Advisers reported no remaining Sanofi Contingent Value Rights position as of Q3 2015 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 10,100 Sanofi Contingent Value Rights shares in Q3 2015, an estimated $7K.
  • Gabelli & Co Investment Advisers first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 9 quarters.
  • Gabelli & Co Investment Advisers's Sanofi Contingent Value Rights position peaked at $1.8M in Q3 2013.
  • 117 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2015.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2015, filed 23 Oct 2015.